Talphera Inc. Insider Trading

TLPH

⊜ Compare

Last 12 months

Insiders bought 304K on the open market and sold nothing.

Net open-market

+304K

5 buys · 0 sales

Under a 10b5-1 plan

—

no sales

Insiders who bought / sold

4 / 0

executives and directors

Last open-market buy

Mar 2026

Mar 13, 2026

Get an email when TLPH's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Mar 13	Vincent J. Angotti Chief Executive Officer	Bought	213,310	$0.59	126K	36%	Form 4
Feb 12	Shakil Aslam Chief Medical Officer	Bought	35,000	$0.81	28K	73%	Form 4
Feb 12	Vincent J. Angotti Chief Executive Officer	Bought	105,364	$0.81	85K	22%	Form 4
Feb 12	Raffi Asadorian Chief Financial Officer	Bought	45,000	$0.81	36K	33%	Form 4
Feb 12	Badri N Dasu Chief Engineering Officer	Bought	35,000	$0.81	28K	90%	Form 4
Apr 2, 2025	Vincent J. Angotti Chief Executive Officer	Bought	213,310	$0.59	126K	82%	Form 4
Dec 5, 2024	Vincent J. Angotti Chief Executive Officer	Bought	5,000	$0.64	3K	2.5%	Form 4
Dec 2, 2024	Raffi Asadorian Chief Financial Officer	SoldNo plan	155	$0.77	$119	0.4%	Form 4
Nov 27, 2024	Vincent J. Angotti Chief Executive Officer	Bought	5,000	$0.73	4K	2.5%	Form 4

Mar 13
Vincent J. Angotti
Chief Executive Officer · bought 213,310 at $0.59
126K
36% of stake
Feb 12
Shakil Aslam
Chief Medical Officer · bought 35,000 at $0.81
28K
73% of stake
Feb 12
Vincent J. Angotti
Chief Executive Officer · bought 105,364 at $0.81
85K
22% of stake
Feb 12
Raffi Asadorian
Chief Financial Officer · bought 45,000 at $0.81
36K
33% of stake
Feb 12
Badri N Dasu
Chief Engineering Officer · bought 35,000 at $0.81
28K
90% of stake
Apr 2, 2025
Vincent J. Angotti
Chief Executive Officer · bought 213,310 at $0.59
126K
82% of stake
Dec 5, 2024
Vincent J. Angotti
Chief Executive Officer · bought 5,000 at $0.64
3K
2.5% of stake
Dec 2, 2024No plan
Raffi Asadorian
Chief Financial Officer · sold 155 at $0.77
$119
0.4% of stake
Nov 27, 2024
Vincent J. Angotti
Chief Executive Officer · bought 5,000 at $0.73
4K
2.5% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch TLPH, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Pharmaceutical Preparations · Pick stocks to compare with TLPH

CompareIntrinsic value

TCRTAlaunos Therapeutics Inc.

$1.80-3.23%10

ASBPAspire Biopharma Holdings Inc.

$7.27-0.41%20

GNLXGenelux Corp.

$1.96+2.08%10

CELZCreative Medical Technology Holdings Inc.

$0.65-3.21%10

CABRCaring Brands, Inc.

$0.90-26.83%10

Spot a number that looks wrong? Check it in TLPH's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing TLPH

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.